ArticleNational science review2026
Simultaneous single-base resolution profiling of 5mC and 5hmC using BRIGHT-seq.
Article in National science review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytosine modifications in DNA, particularly 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), are key epigenetic marks involved in gene regulation and chromatin organization. Simultaneous and base-resolution detection of 5mC and 5hmC is essential for understanding their interplay in gene regulation. However, existing methods often rely on differential subtraction strategies, making direct and concurrent analysis within a single assay challenging. Here, we present the Base Replacement for Integrated Genome-wide Methylation and Hydroxymethylation Tracking Sequencing (BRIGHT-seq), a sequencing strategy that enables direct and simultaneous detection of 5mC and 5hmC at single-base resolution within the same DNA molecule. By integrating enzymatic and chemical treatments, BRIGHT-seq converts 5mC to adenine and 5hmC to thymine, enabling direct identification of both modifications without relying on differential subtraction. We demonstrate the applicability of BRIGHT-seq by mapping 5mC and 5hmC landscapes across human and mouse genomes. BRIGHT-seq provides a useful and high-resolution tool for epigenetic research, facilitating future studies on the roles of 5mC and 5hmC in gene regulation and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.